125 related articles for article (PubMed ID: 16336216)
1. Regulation of endogenous human NPFF2 receptor by neuropeptide FF in SK-N-MC neuroblastoma cell line.
Ankö ML; Panula P
J Neurochem; 2006 Jan; 96(2):573-84. PubMed ID: 16336216
[TBL] [Abstract][Full Text] [Related]
2. Neuropeptide FF (NPFF) analogs functionally antagonize opioid activities in NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells.
Mollereau C; Mazarguil H; Zajac JM; Roumy M
Mol Pharmacol; 2005 Mar; 67(3):965-75. PubMed ID: 15608144
[TBL] [Abstract][Full Text] [Related]
3. Pain- and morphine-associated transcriptional regulation of neuropeptide FF and the G-protein-coupled NPFF2 receptor gene.
Nystedt JM; Lemberg K; Lintunen M; Mustonen K; Holma R; Kontinen VK; Kalso E; Panula P
Neurobiol Dis; 2004 Jun; 16(1):254-62. PubMed ID: 15207282
[TBL] [Abstract][Full Text] [Related]
4. Rat NPFF(1) receptor-mediated signaling: functional comparison of neuropeptide FF (NPFF), FMRFamide and PFR(Tic)amide.
Chen JC; Lee WH; Chen PC; Tseng CP; Huang EY
Peptides; 2006 May; 27(5):1005-14. PubMed ID: 16490283
[TBL] [Abstract][Full Text] [Related]
5. Staurosporine differentiation of NPFF2 receptor-transfected SH-SY5Y neuroblastoma cells induces selectivity of NPFF activity towards opioid receptors.
Mollereau C; Zajac JM; Roumy M
Peptides; 2007 May; 28(5):1125-8. PubMed ID: 17418451
[TBL] [Abstract][Full Text] [Related]
6. Anti-opioid activities of NPFF1 receptors in a SH-SY5Y model.
Kersanté F; Mollereau C; Zajac JM; Roumy M
Peptides; 2006 May; 27(5):980-9. PubMed ID: 16488058
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide FF-sensitive confinement of mu opioid receptor does not involve lipid rafts in SH-SY5Y cells.
Moulédous L; Merker S; Neasta J; Roux B; Zajac JM; Mollereau C
Biochem Biophys Res Commun; 2008 Aug; 373(1):80-4. PubMed ID: 18544342
[TBL] [Abstract][Full Text] [Related]
8. Alternative splicing of human and mouse NPFF2 receptor genes: Implications to receptor expression.
Ankö ML; Ostergård M; Lintunen M; Panula P
FEBS Lett; 2006 Dec; 580(30):6955-60. PubMed ID: 17157836
[TBL] [Abstract][Full Text] [Related]
9. Comparison of pharmacological activities of Neuropeptide FF1 and Neuropeptide FF2 receptor agonists.
Quelven I; Roussin A; Zajac JM
Eur J Pharmacol; 2005 Jan; 508(1-3):107-14. PubMed ID: 15680260
[TBL] [Abstract][Full Text] [Related]
10. Opposite control of body temperature by NPFF1 and NPFF2 receptors in mice.
Moulédous L; Barthas F; Zajac JM
Neuropeptides; 2010 Oct; 44(5):453-6. PubMed ID: 20554321
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a neuronal cell line expressing native human melanin-concentrating hormone receptor 1 (MCHR1).
Fry D; Dayton B; Brodjian S; Ogiela C; Sidorowicz H; Frost LJ; McNally T; Reilly RM; Collins CA
Int J Biochem Cell Biol; 2006; 38(8):1290-9. PubMed ID: 16524757
[TBL] [Abstract][Full Text] [Related]
12. Neuropeptide FF, but not prolactin-releasing peptide, mRNA is differentially regulated in the hypothalamic and medullary neurons after salt loading.
Kalliomäki ML; Panula P
Neuroscience; 2004; 124(1):81-7. PubMed ID: 14960341
[TBL] [Abstract][Full Text] [Related]
13. Activation of NPFF
Yu HP; Zhang N; Zhang T; Wang ZL; Li N; Tang HH; Zhang R; Zhang MN; Xu B; Fang Q; Wang R
Peptides; 2016 Dec; 86():24-32. PubMed ID: 27669639
[TBL] [Abstract][Full Text] [Related]
14. Functional expression of neuropeptide Y receptors in human neuroblastoma cells.
Li AJ; Ritter S
Regul Pept; 2005 Jul; 129(1-3):119-24. PubMed ID: 15927706
[TBL] [Abstract][Full Text] [Related]
15. Cellular mechanisms of growth inhibition of human endometrial cancer cell line by an antagonist of growth hormone-releasing hormone.
Zhao L; Yano T; Osuga Y; Nakagawa S; Oishi H; Wada-Hiraike O; Tang X; Yano N; Kugu K; Schally AV; Taketani Y
Int J Oncol; 2008 Mar; 32(3):593-601. PubMed ID: 18292936
[TBL] [Abstract][Full Text] [Related]
16. Identification and characterization of two G protein-coupled receptors for neuropeptide FF.
Bonini JA; Jones KA; Adham N; Forray C; Artymyshyn R; Durkin MM; Smith KE; Tamm JA; Boteju LW; Lakhlani PP; Raddatz R; Yao WJ; Ogozalek KL; Boyle N; Kouranova EV; Quan Y; Vaysse PJ; Wetzel JM; Branchek TA; Gerald C; Borowsky B
J Biol Chem; 2000 Dec; 275(50):39324-31. PubMed ID: 11024015
[TBL] [Abstract][Full Text] [Related]
17. Neuropeptide FF activates ERK and NF kappa B signal pathways in differentiated SH-SY5Y cells.
Sun YL; Zhang XY; He N; Sun T; Zhuang Y; Fang Q; Wang KR; Wang R
Peptides; 2012 Nov; 38(1):110-7. PubMed ID: 22981806
[TBL] [Abstract][Full Text] [Related]
18. Regulation and expression of D-1, but not D-5, dopamine receptors in human SK-N-MC neuroblastoma cells.
Sidhu A
J Recept Signal Transduct Res; 1997 Sep; 17(5):777-84. PubMed ID: 9292777
[TBL] [Abstract][Full Text] [Related]
19. The signalling profile of recombinant human orexin-2 receptor.
Tang J; Chen J; Ramanjaneya M; Punn A; Conner AC; Randeva HS
Cell Signal; 2008 Sep; 20(9):1651-61. PubMed ID: 18599270
[TBL] [Abstract][Full Text] [Related]
20. Assessing activation of the human neuropeptide FF2 receptor with a non-radioactive GTP binding assay.
Engström M; Närvänen A; Savola JM; Wurster S
Peptides; 2004 Dec; 25(12):2099-104. PubMed ID: 15572197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
